Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to evaluate the efficacy and safety of TVAX-008 for chronic hepatitis B, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TVAX-008

Snippet

Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. | Conditions: Chronic hepatitisB | Phase 3 | Status: NOT_YET_RECRUITING